Fig. 2From: Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial moleculesShowing the average particle size distribution histogram and zeta potential of ZnO nanoparticle and the reducing/capping agent A depicts average particle size distribution a ZnO nanoparticles (ZnO NPs) and b beta-cyclodextrin capped ZnO NPs (ZnO-BCD NPs) and B showing zeta potential graph of a ZnO nanoparticles (ZnO NPs) and b beta-cyclodextrin capped ZnO NPs (ZnO-BCD NPs)Back to article page